Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Sims-Mourtada

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2021
A Population Health Assessment in a Community Cancer Center Catchment Area: Triple-Negative Breast Cancer, Alcohol Use, and Obesity in New Castle County, DelawareScott D Siegel, Madeline M Brooks, Jennifer Sims-Mourtada, et al.
Cancer Growth and Metastasis|March 20, 2018
The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation SchedulesKimberly M Arnold, Nicole J Flynn, Adam Raben, et al.
Scientific Reports|January 17, 2025
B cells enhance IL-1 beta driven invasiveness in triple negative breast cancerNicole J Toney, Lynn M Opdenaker, Lisa Frerichs, et al.
Research Square|January 13, 2025
B cells enhance IL-1 beta driven invasiveness in triple-negative breast cancerNicole J Toney, Lynn M Opdenaker, Lisa Frerichs, et al.
Brachytherapy|September 10, 2023
Actinium-225 Targeted Agents: Where Are We Now?Firas Mourtada, Katsumi Tomiyoshi, Jennifer Sims-Mourtada, et al.
Cancer Medicine|March 14, 2023
Neighborhood factors and triple negative breast cancer: The role of cumulative exposure to area-level risk factorsScott D Siegel, Madeline M Brooks, Jesse D Berman, et al.
European Journal of Organic Chemistry|March 30, 2019
A Strategy toward Icetexane Natural ProductsDaniel J Moon, Mohammad Al-Amin, Robert S Lewis, et al.
Journal of Translational Medicine|March 8, 2022
Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancersNicole J Toney, Lynn M Opdenaker, Kader Cicek, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 3, 2008
Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumorsEbrahim S Delpassand, Jennifer Sims-Mourtada, Hitomi Saso, et al.
Materials Today. Bio|November 29, 2021
Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffoldsMarc Rabionet, Emma Polonio-Alcalá, Joana Relat, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2021
A Population Health Assessment in a Community Cancer Center Catchment Area: Triple-Negative Breast Cancer, Alcohol Use, and Obesity in New Castle County, DelawareScott D Siegel, Madeline M Brooks, Jennifer Sims-Mourtada, et al.
Cancer Growth and Metastasis|March 20, 2018
The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation SchedulesKimberly M Arnold, Nicole J Flynn, Adam Raben, et al.
Scientific Reports|January 17, 2025
B cells enhance IL-1 beta driven invasiveness in triple negative breast cancerNicole J Toney, Lynn M Opdenaker, Lisa Frerichs, et al.
Research Square|January 13, 2025
B cells enhance IL-1 beta driven invasiveness in triple-negative breast cancerNicole J Toney, Lynn M Opdenaker, Lisa Frerichs, et al.
Brachytherapy|September 10, 2023
Actinium-225 Targeted Agents: Where Are We Now?Firas Mourtada, Katsumi Tomiyoshi, Jennifer Sims-Mourtada, et al.
Cancer Medicine|March 14, 2023
Neighborhood factors and triple negative breast cancer: The role of cumulative exposure to area-level risk factorsScott D Siegel, Madeline M Brooks, Jesse D Berman, et al.
European Journal of Organic Chemistry|March 30, 2019
A Strategy toward Icetexane Natural ProductsDaniel J Moon, Mohammad Al-Amin, Robert S Lewis, et al.
Journal of Translational Medicine|March 8, 2022
Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancersNicole J Toney, Lynn M Opdenaker, Kader Cicek, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 3, 2008
Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumorsEbrahim S Delpassand, Jennifer Sims-Mourtada, Hitomi Saso, et al.
Materials Today. Bio|November 29, 2021
Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffoldsMarc Rabionet, Emma Polonio-Alcalá, Joana Relat, et al.
Pageof 4